Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

Limits of Patentability: Plant Sciences, Stem Cells and Nucleic Acids

-15% su kodu: ENG15
71,98 
Įprasta kaina: 84,68 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
71,98 
Įprasta kaina: 84,68 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 84.6800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 20,00 

Knygos aprašymas

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer¿s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.

Informacija

Autorius: Andreas Hübel, Aloys Hüttermann, Ulrich Storz,
Serija: SpringerBriefs in Biotech Patents
Leidėjas: Springer Berlin Heidelberg
Išleidimo metai: 2012
Knygos puslapių skaičius: 56
ISBN-10: 3642328407
ISBN-13: 9783642328404
Formatas: 235 x 155 x 4 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Limits of Patentability: Plant Sciences, Stem Cells and Nucleic Acids“

Būtina įvertinti prekę